Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
The Journal of Family Practice
|
September 1, 1996
New agent for obesity management
R L Barkin
American Family Physician
|
March 23, 2001
Pharmacotherapy for nonmalignant pain
R L Barkin
American Journal of Therapeutics
|
November 13, 2001
Acetaminophen, aspirin, or Ibuprofen in combination analgesic products
R L Barkin
Pharmacotherapy
|
March 1, 1997
Cancer pain treatment insights
R L Barkin
Pharmacotherapy
|
September 1, 1996
Withdrawal syndrome is not precipitated when butorphanol is added to opiate or opioid therapy. A comment on intranasal butorphanol-induced apraxia reversed by naloxone
R L Barkin
Journal of Affective Disorders
|
May 20, 1999
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
J Fawcett, R L Barkin
The Journal of Clinical Psychiatry
|
January 1, 1997
Efficacy issues with antidepressants
J Fawcett, R L Barkin
American Family Physician
|
October 3, 1999
Clinical pharmacology of mirtazapine: revisited
J Davis, R L Barkin
Southern Medical Journal
|
September 11, 2001
Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection
R L Barkin, D Barkin
American Journal of Therapeutics
|
April 25, 2001
The management challenges of chronic pain: the role of antidepressants
R L Barkin, J Fawcett
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
The Journal of Family Practice
|
September 1, 1996
New agent for obesity management
R L Barkin
American Family Physician
|
March 23, 2001
Pharmacotherapy for nonmalignant pain
R L Barkin
American Journal of Therapeutics
|
November 13, 2001
Acetaminophen, aspirin, or Ibuprofen in combination analgesic products
R L Barkin
Pharmacotherapy
|
March 1, 1997
Cancer pain treatment insights
R L Barkin
Pharmacotherapy
|
September 1, 1996
Withdrawal syndrome is not precipitated when butorphanol is added to opiate or opioid therapy. A comment on intranasal butorphanol-induced apraxia reversed by naloxone
R L Barkin
Journal of Affective Disorders
|
May 20, 1999
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
J Fawcett, R L Barkin
The Journal of Clinical Psychiatry
|
January 1, 1997
Efficacy issues with antidepressants
J Fawcett, R L Barkin
American Family Physician
|
October 3, 1999
Clinical pharmacology of mirtazapine: revisited
J Davis, R L Barkin
Southern Medical Journal
|
September 11, 2001
Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection
R L Barkin, D Barkin
American Journal of Therapeutics
|
April 25, 2001
The management challenges of chronic pain: the role of antidepressants
R L Barkin, J Fawcett
Page
of 4